Macmic Science&Technology Co.,Ltd. Logo

Macmic Science&Technology Co.,Ltd.

688711.SS

(2.8)
Stock Price

18,80 CNY

2.26% ROA

4.91% ROE

69.39x PER

Market Cap.

4.525.698.464,00 CNY

73.67% DER

0.42% Yield

4.09% NPM

Macmic Science&Technology Co.,Ltd. Stock Analysis

Macmic Science&Technology Co.,Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Macmic Science&Technology Co.,Ltd. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (50%), which means it has a small amount of debt compared to the ownership it holds

2 Revenue Growth

With a track record of consistent revenue growth in the past five years, this company presents a compelling opportunity.

3 Net Profit Growth

The net profit of this company has steadily increased over the last five years, showcasing a favorable financial performance and making it an enticing option for investors seeking growth potential.

4 Assets Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

5 ROE

The stock's ROE falls within an average range (11.06%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

6 ROA

The stock's ROA (5.49%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

7 Buffet Intrinsic Value

The company's stock presents an enticing opportunity as it appears undervalued (866) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

8 PBV

The stock's high Price-to-Book Value (P/BV) ratio (7.29x) suggests it's overvalued, potentially making it an expensive investment.

9 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

10 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

11 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

Macmic Science&Technology Co.,Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Macmic Science&Technology Co.,Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Macmic Science&Technology Co.,Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Macmic Science&Technology Co.,Ltd. Revenue
Year Revenue Growth
2012 102.281.417
2013 133.470.302 23.37%
2014 133.454.935 -0.01%
2015 131.371.586 -1.59%
2016 192.330.535 31.69%
2017 209.175.164 8.05%
2018 262.492.733 20.31%
2019 259.720.895 -1.07%
2020 331.629.293 21.68%
2021 550.636.072 39.77%
2022 926.083.797 40.54%
2023 1.484.037.345 37.6%
2023 1.503.262.696 1.28%
2024 1.558.186.088 3.52%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Macmic Science&Technology Co.,Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
2012 9.847.011
2013 10.763.349 8.51%
2014 0 0%
2015 0 0%
2016 0 0%
2017 17.759.218 100%
2018 22.089.615 19.6%
2019 24.559.566 10.06%
2020 23.006.291 -6.75%
2021 37.901.236 39.3%
2022 64.277.954 41.04%
2023 112.646.289 42.94%
2023 102.754.035 -9.63%
2024 104.471.576 1.64%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Macmic Science&Technology Co.,Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 14.838.393
2013 17.676.916 16.06%
2014 20.912.960 15.47%
2015 22.253.041 6.02%
2016 25.505.081 12.75%
2017 7.883.721 -223.52%
2018 2.820.159 -179.55%
2019 2.387.743 -18.11%
2020 2.952.214 19.12%
2021 5.274.273 44.03%
2022 7.419.768 28.92%
2023 132.889.605 94.42%
2023 29.290.994 -353.69%
2024 -37.927.355 177.23%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Macmic Science&Technology Co.,Ltd. EBITDA
Year EBITDA Growth
2012 10.910.625
2013 16.802.452 35.07%
2014 16.661.162 -0.85%
2015 10.191.185 -63.49%
2016 19.613.437 48.04%
2017 21.794.846 10.01%
2018 31.459.514 30.72%
2019 27.220.780 -15.57%
2020 44.473.477 38.79%
2021 93.331.118 52.35%
2022 114.224.188 18.29%
2023 132.567.758 13.84%
2023 163.392.050 18.87%
2024 52.027.040 -214.05%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Macmic Science&Technology Co.,Ltd. Gross Profit
Year Gross Profit Growth
2012 28.615.790
2013 38.227.032 25.14%
2014 38.590.633 0.94%
2015 32.594.199 -18.4%
2016 44.026.189 25.97%
2017 48.644.993 9.49%
2018 59.501.106 18.25%
2019 61.569.966 3.36%
2020 78.220.953 21.29%
2021 118.784.025 34.15%
2022 193.559.948 38.63%
2023 321.254.950 39.75%
2023 321.571.620 0.1%
2024 224.016.880 -43.55%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Macmic Science&Technology Co.,Ltd. Net Profit
Year Net Profit Growth
2012 11.557.392
2013 22.731.149 49.16%
2014 9.879.891 -130.07%
2015 4.161.628 -137.4%
2016 11.592.976 64.1%
2017 5.674.958 -104.28%
2018 7.534.170 24.68%
2019 11.210.491 32.79%
2020 26.637.905 57.92%
2021 68.829.391 61.3%
2022 78.708.087 12.55%
2023 92.171.785 14.61%
2023 116.194.855 20.67%
2024 16.921.144 -586.68%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Macmic Science&Technology Co.,Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 0
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 1 0%
2023 1 0%
2023 1 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Macmic Science&Technology Co.,Ltd. Free Cashflow
Year Free Cashflow Growth
2012 -5.907.709
2013 -1.932.898 -205.64%
2014 10.846.552 117.82%
2015 7.407.960 -46.42%
2016 165.840 -4366.93%
2017 -888.801 118.66%
2018 -11.840.595 92.49%
2019 -10.554.259 -12.19%
2020 -31.094.746 66.06%
2021 -122.481.792 74.61%
2022 -211.308.513 42.04%
2023 -347.923.897 39.27%
2023 -46.905.678 -641.75%
2024 -10.820.590 -333.49%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Macmic Science&Technology Co.,Ltd. Operating Cashflow
Year Operating Cashflow Growth
2012 -1.943.784
2013 12.412.909 115.66%
2014 24.298.715 48.92%
2015 17.165.239 -41.56%
2016 9.861.783 -74.06%
2017 12.449.941 20.79%
2018 9.906.470 -25.67%
2019 6.268.716 -58.03%
2020 4.370.517 -43.43%
2021 -74.074.929 105.9%
2022 -81.394.059 8.99%
2023 -141.711.501 42.56%
2023 -13.867.123 -921.92%
2024 18.573.728 174.66%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Macmic Science&Technology Co.,Ltd. Capital Expenditure
Year Capital Expenditure Growth
2012 3.963.925
2013 14.345.807 72.37%
2014 13.452.163 -6.64%
2015 9.757.279 -37.87%
2016 9.695.943 -0.63%
2017 13.338.742 27.31%
2018 21.747.065 38.66%
2019 16.822.975 -29.27%
2020 35.465.263 52.56%
2021 48.406.863 26.74%
2022 129.914.454 62.74%
2023 206.212.396 37%
2023 33.038.555 -524.16%
2024 29.394.318 -12.4%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Macmic Science&Technology Co.,Ltd. Equity
Year Equity Growth
2012 74.155.642
2013 96.886.792 23.46%
2014 106.766.683 9.25%
2015 110.928.309 3.75%
2016 127.295.783 12.86%
2017 148.673.489 14.38%
2018 166.712.592 10.82%
2019 155.822.697 -6.99%
2020 232.360.898 32.94%
2021 876.502.937 73.49%
2022 965.686.490 9.24%
2023 1.157.410.625 16.56%
2023 1.142.795.062 -1.28%
2024 1.127.698.576 -1.34%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Macmic Science&Technology Co.,Ltd. Assets
Year Assets Growth
2012 162.540.760
2013 188.851.366 13.93%
2014 182.280.021 -3.61%
2015 190.947.586 4.54%
2016 234.616.093 18.61%
2017 285.213.165 17.74%
2018 319.215.176 10.65%
2019 339.521.660 5.98%
2020 424.798.946 20.07%
2021 1.280.714.866 66.83%
2022 1.688.986.350 24.17%
2023 2.624.113.228 35.64%
2023 2.488.990.937 -5.43%
2024 2.523.877.137 1.38%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Macmic Science&Technology Co.,Ltd. Liabilities
Year Liabilities Growth
2012 88.385.117
2013 91.964.574 3.89%
2014 75.513.337 -21.79%
2015 60.944.559 -23.9%
2016 83.470.155 26.99%
2017 136.539.675 38.87%
2018 152.502.583 10.47%
2019 183.698.962 16.98%
2020 192.438.047 4.54%
2021 404.211.929 52.39%
2022 723.299.859 44.12%
2023 1.466.702.603 50.69%
2023 1.294.175.373 -13.33%
2024 1.347.674.345 3.97%

Macmic Science&Technology Co.,Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
7.52
Net Income per Share
0.31
Price to Earning Ratio
69.39x
Price To Sales Ratio
3.29x
POCF Ratio
139.82
PFCF Ratio
-37.36
Price to Book Ratio
3.45
EV to Sales
3.81
EV Over EBITDA
74.32
EV to Operating CashFlow
187.83
EV to FreeCashFlow
-43.25
Earnings Yield
0.01
FreeCashFlow Yield
-0.03
Market Cap
4,53 Bil.
Enterprise Value
5,24 Bil.
Graham Number
6.53
Graham NetNet
-2.72

Income Statement Metrics

Net Income per Share
0.31
Income Quality
0.5
ROE
0.05
Return On Assets
0.02
Return On Capital Employed
0.02
Net Income per EBT
1.27
EBT Per Ebit
1.08
Ebit per Revenue
0.03
Effective Tax Rate
-0.18

Margins

Sales, General, & Administrative to Revenue
0.02
Research & Developement to Revenue
0.08
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.19
Operating Profit Margin
0.03
Pretax Profit Margin
0.03
Net Profit Margin
0.04

Dividends

Dividend Yield
0
Dividend Yield %
0.42
Payout Ratio
0.55
Dividend Per Share
0.09

Operating Metrics

Operating Cashflow per Share
0.15
Free CashFlow per Share
-0.66
Capex to Operating CashFlow
5.34
Capex to Revenue
0.11
Capex to Depreciation
6.67
Return on Invested Capital
0.02
Return on Tangible Assets
0.02
Days Sales Outstanding
154.71
Days Payables Outstanding
133.02
Days of Inventory on Hand
152.21
Receivables Turnover
2.36
Payables Turnover
2.74
Inventory Turnover
2.4
Capex per Share
0.81

Balance Sheet

Cash per Share
0,99
Book Value per Share
6,43
Tangible Book Value per Share
6.23
Shareholders Equity per Share
6.17
Interest Debt per Share
4.71
Debt to Equity
0.74
Debt to Assets
0.33
Net Debt to EBITDA
10.11
Current Ratio
1.44
Tangible Asset Value
1,14 Bil.
Net Current Asset Value
-0,10 Bil.
Invested Capital
1387322380
Working Capital
0,38 Bil.
Intangibles to Total Assets
0.01
Average Receivables
0,52 Bil.
Average Payables
0,34 Bil.
Average Inventory
479524351
Debt to Market Cap
0.18

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Macmic Science&Technology Co.,Ltd. Dividends
Year Dividends Growth
2022 0
2023 0 0%
2024 0 0%

Macmic Science&Technology Co.,Ltd. Profile

About Macmic Science&Technology Co.,Ltd.

Macmic Science & Technology Co., Ltd. develops, manufactures, and sells power semiconductor products and solutions. The company offers MOSFET modules; fast recovery epitaxial diode chips, discrete products, and modules; IGBT discrete products and modules; rectifier diode modules and three-phase rectifier bridge modules; and thyristor modules. Its products have applications in inverter, welding, SMPS, UPS, induction heating, solar and wind-power inverter, and transportation products, as well as home appliances, electric vehicles, medical equipment, and motor drives. The company was founded in 2006 and is based in Taipei, Taiwan.

CEO
Mr. Shanqi Zhao
Employee
1.119
Address
5, No. 202, Nanjing East Road
Taipei, 10570

Macmic Science&Technology Co.,Ltd. Executives & BODs

Macmic Science&Technology Co.,Ltd. Executives & BODs
# Name Age
1 Mr. Donglai Chang
Deputy General Manager
70
2 Mr. Siping Li
Deputy GM & Director
70
3 Mr. Xiaobao Wang
Deputy General Manager
70
4 Mr. Ziwen Ding
Deputy GM, Board Secretary & Director
70
5 Ms. Chunfeng Xu
Deputy General Manager
70
6 Mr. Lifeng Liu
Deputy GM & Director
70
7 Mr. Shanqi Zhao
Chairman & GM
70

Macmic Science&Technology Co.,Ltd. Competitors